Screener
Medtronic MDT United States — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | U.S. / Fiscal Year / 2026 | U.S. / Fiscal Year / 2025 | U.S. / Fiscal Year / 2024 | International / Fiscal Year / 2026 | International / Fiscal Year / 2025 | International / Fiscal Year / 2024 |
|---|---|---|---|---|---|---|
| Cardiovascular | $6,435 | $5,804 | $5,597 | $7,541 | $6,677 | $6,234 |
| Neuroscience | 6,875 | 6,713 | 6,305 | 3,412 | 3,133 | 3,101 |
| Medical Surgical | 3,778 | 3,664 | 3,717 | 5,037 | 4,744 | 4,700 |
| Reportable segment net sales | 17,088 | 16,181 | 15,619 | 15,991 | 14,553 | 14,035 |
| Diabetes | 934 | 923 | 852 | 2,178 | 1,832 | 1,636 |
| Other operating segment(1) | 81 | 68 | 91 | 54 | 70 | 131 |
| Other adjustments(2) | — | — | — | 39 | (90) | — |
| Total net sales | $18,103 | $17,171 | $16,562 | $18,261 | $16,365 | $15,802 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's united states — net sales?
- Medtronic (MDT) reported united states — net sales of $4.87B in Q1 2026.
- How has Medtronic's united states — net sales changed year-over-year?
- Medtronic's united states — net sales increased by 7.1% year-over-year, from $4.55B to $4.87B.
- What is the long-term trend for Medtronic's united states — net sales?
- Over 4 years (2022 to 2026), Medtronic's united states — net sales has grown at a 2.9% compound annual growth rate (CAGR), from $16.13B to $18.1B.
- What does united states — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and related services within the United States geographic segment. It reflects the company's market penetration, pricing power, and demand for its therapeutic solutions in the domestic healthcare market. As a primary revenue driver, it indicates the company's ability to navigate domestic reimbursement environments and hospital procurement cycles.
Ask your AI about Medtronic's united states — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude